Bisphosphonate

Posted on: Wednesday, 10 March 2010, 08: 55 CST Studies find possible links between prolonged bisphosphonate treatments Bisphosphonate treatments, proven to enhance bone density and

WN.com - Articles related to In memory of Mother: Why are vitamin supplements important part two 2010

Bisphosphonate in tablet form is commonly marketed to prevent and treat osteoporosis in post-menopausal women.

Fosamax Does More Harm Than Good 2006

Bisphosphonate pills are routinely prescribed for osteoporosis in postmenopausal women and include brands like Fosamax and Boniva.

SFGate: Top News Stories 2011

Bisphosphonate bone drugs reviewed for cancer risk PEOPLE taking a popular group of bone-strengthening drugs linked to throat cancer have been advised to continue despite an investigation by America's drug regulator.

NEWS.com.au | Top Stories 2011

Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).

PhysOrg.com - latest science and technology news stories PhysOrg Team 2010

"Bisphosphonate use still is a very effective solution that prevents bone loss in most patients and no one is recommending that physicians avoid prescribing these," said Dr. Rosenwasser.

PhysOrg.com - latest science and technology news stories PhysOrg Team 2010

Bisphosphonate exposure was not associated with an increased risk of AF [pooled multivariate OR 1.04, 95% confidence interval (CI) 0. 92-1.16] after adjusting for known risk factors.

BioMed Central - Latest articles Seo Young Kim 2010

Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons

Science Blog BJS 2010

Bisphosphonate drugs such as Zometa are commonly used to reduce the risk of complications from bone metastases.

Cancer News 2010

"Bisphosphonate use still is a very effective solution that prevents bone loss in most patients and no one is recommending that physicians avoid prescribing these," said Dr. Rosenwasser.

Science Blog BJS 2010